A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/195 (2006.01) A61K 31/00 (2006.01) A61K 31/19 (2006.01) A61K 31/215 (2006.01) A61K 31/22 (2006.01) A61K 31/335 (2006.01) A61K 31/34 (2006.01) A61K 31/35 (2006.01) A61K 31/38 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) A61K 31/66 (2006.01)
Patent
CA 2147123
A method of reducing the damaging effect of an injury to mammalian cells by treatment of the cell or mammalian tissue in vivo with a cell membrane permeant calcium buffer. The method comprises treating mammalian tissue with a damage reducing effective amount of the calcium buffer, preferably, a BAPTA derivative. The method may be used to control the concentration of Ca2+ ions in the vicinity of ion channel pores of the cells to prevent diffusion of toxic amounts of Ca2+ ions to subcellular sites located near the source of Ca2+ influx. The buffer treatment may be applied as a prophylactic or after the mammalian tissue has sustained injury. Pharmaceutical compositions comprising the calcium buffer and method of manufacture therefor are described.
Charlton Milton P.
Tymianski Michael
Charlton Milton P.
Gowan Intellectual Property
Tymianski Michael
LandOfFree
Use of a cell membrane permeant calcium buffer for reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a cell membrane permeant calcium buffer for reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a cell membrane permeant calcium buffer for reducing... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1546568